BUSINESS● LOWAug 28 · Aug 28, 2026, 10:48 AM
Pfizer-backed Priovant wins FDA approval for lead asset
Seeking Alpha Tech · north america
Priovant, a company supported by Pfizer, has received FDA approval for its primary product. This marks a significant regulatory milestone for the pharmaceutical asset.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS35m agoSanlamAllianz: why the insurance giant is slow to attract global fundsJeune AfriqueBUSINESS43m agoStock futures fall as Amazon and Intel results weigh on NasdaqSeeking Alpha Tech